Kymera Therapeutics Inc. (KYMR) Social Stream



Kymera Therapeutics Inc. (KYMR): $13.90

0.40 (-2.80%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add KYMR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#296 of 359

in industry

KYMERA THERAPEUTICS INC (KYMR) Price Targets From Analysts

Use the tables below to see what analysts covering KYMERA THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-03 10 $85 $67 $77.5 $14.3 441.96%
2022-02-24 11 $91 $62 $77 $14.3 438.46%
2022-02-28 11 $91 $62 $74.222 $14.3 419.03%
2022-03-02 11 $91 $62 $74 $14.3 417.48%
2022-04-10 12 $91 $44 $71 $14.3 396.5%
2022-05-03 11 $91 $44 $71 $14.3 396.5%
2022-05-04 11 $91 $35 $65.2 $14.3 355.94%
2022-05-09 11 $91 $35 $64.2 $14.3 348.95%
2022-05-22 10 $91 $35 $62.444 $14.3 336.67%
2022-06-01 10 $85 $35 $57.111 $14.3 299.38%
2022-06-15 10 $85 $35 $54.111 $14.3 278.4%
2022-06-21 10 $93 $35 $55.555 $14.3 288.5%
2022-07-20 10 $93 $26 $52.6 $14.3 267.83%
2022-08-03 11 $93 $26 $51.454 $14.3 259.82%
2022-08-12 12 $93 $26 $51.454 $14.3 259.82%
2022-08-13 13 $93 $26 $51.454 $14.3 259.82%
2022-08-22 13 $93 $26 $50.5 $14.3 253.15%
2022-10-13 12 $93 $26 $50.666 $14.3 254.31%
2022-11-04 13 $93 $26 $50.666 $14.3 254.31%
2022-11-07 14 $93 $26 $49.166 $14.3 243.82%
2022-12-11 14 $93 $26 $49.25 $14.3 244.41%
2022-12-15 14 $93 $31 $51.5 $14.3 260.14%
2022-12-19 14 $93 $31 $52.75 $14.3 268.88%
2023-01-02 14 $93 $31 $52.666 $14.3 268.29%
2023-02-24 14 $93 $31 $53.166 $14.3 271.79%
2023-03-03 14 $93 $31 $52.916 $14.3 270.04%
2023-05-04 14 $93 $31 $52.916 $14.3 270.04%
2023-05-08 14 $93 $31 $51.384 $14.3 259.33%
2023-06-22 14 $93 $31 $51.23 $14.3 258.25%
2023-06-30 15 $93 $31 $51.142 $14.3 257.64%
2023-08-04 14 $93 $31 $52.153 $14.3 264.71%
2023-08-07 13 $93 $31 $52.461 $14.3 266.86%
2023-08-29 13 $93 $31 $52.23 $14.3 265.24%

The Trend in the Analyst Price Target


Over the past 15 months, KYMR's average price target has gone down $4.88.

Over the past 46 weeks, KYMR's average upside potential has been 102.18%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-04 13 93 26 50.666 30.86 64.18%
2022-12-19 14 93 31 52.750 26.39 99.89%
2023-01-10 14 93 31 53.166 29.50 80.22%
2023-02-08 14 93 31 53.166 34.29 55.05%
2023-05-08 14 93 31 51.384 27.74 85.23%

KYMR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.62 9 0 4 0 0 13

The Trend in the Broker Recommendations


KYMR's average broker recommendation rating worsened by 0.62 over the prior 35 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • KYMR has a greater upside potential (average analyst target price relative to current price) than 3455.07% of all US stocks.
  • KYMR has a lower variance in analysts' estimates than -3161.5% of all US stocks.
  • In the context of stocks in the mid market cap category, KYMERA THERAPEUTICS INC's number of analysts covering the stock is higher than 3368.12% of them.
  • In the context of Pharmaceutical Products stocks, KYMERA THERAPEUTICS INC's average analyst price target is greater than 2834.75% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to KYMERA THERAPEUTICS INC are CCCC, ABCM, and BCAB.

Make investment decisions regarding KYMR using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!